Immune Checkpoint Inhibitors Myocarditis: 1% Risk, 50% Fatal – UCSF Insights Other 3 Mins Read Immune checkpoint inhibitors myocarditis poses a serious threat in cancer care. These drugs fight tumors well. However, they can inflame…
2025 Melanoma Immunotherapy: Exercise & Microbiome Immunotherapy 3 Mins Read The 2025 Cell article by Catherine M. Phelps et al. from the University of Pittsburgh reveals a key connection between…
Are there any specific patient subgroups who may benefit more or less from TTFields treatment? Acute Lymphoblastic Leukemia 1 Min Read Ticiana Leal, MD, from the Winship Cancer Institute of Emory University, shared her insights during a discussion with Allen Wilbanks…
